drugset / Trial / NCT00206258

The Role of Amylin and Glucagon in T1DM

NCT00206258

Phase 3 Completed 30 enrolled Baylor College of Medicine
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if giving pramlintide and insulin before a meal would lower high blood sugar and if a glucagon (a naturally made hormone in the body but reduced in diabetes and its role is in prevention of low blood sugar) shot given in the late "after meal" time would prevent low blood sugar. The studies outlined in this proposal might help in developing new treatment options to target "after meal" high blood sugar and before meal low blood sugar in children. This would possibly help improve overall blood sugar control and prevent the long-term complications of diabetes.

Timeline

Start
2002-07
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucagon Peptide
Subject Pramlintide Peptide 30 ug
Subject Pramlintide Peptide 45 ug